Announcements Trials

Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 18 Breast Neoplasms 16 Lung Neoplasms 10 Carcinoma, Non-Small-Cell Lung 6 Prostatic Neoplasms 5 Melanoma 5 Colorectal Neoplasms 5 Brain Neoplasms 5 Pancreatic Neoplasms 4 Ovarian Neoplasms 4 Uterine Cervical Neoplasms 3 Triple Negative Breast Neoplasms 3 Skin Neoplasms 3 Myeloproliferative Disorders 3 Leukemia, Myeloid, Acute 3 Kidney Neoplasms 3 Head and Neck Neoplasms 3 Carcinoma, Hepatocellular 3 Recurrence 2 Neoplasm, Residual 2 Neoplasm Metastasis 2 Myelodysplastic Syndromes 2 Lymphoma, Non-Hodgkin 2 Lymphoma, B-Cell 2 Lung Diseases 2 Glioma 2 Glioblastoma 2 Genetic Predisposition to Disease 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2

Interventions

Cyclophosphamide 3 fludarabine phosphate 2 Whole-Body Irradiation 2 Tacrolimus 2 Specimen Handling 2 Peripheral Blood Stem Cell Transplantation 2 Nivolumab 2 Mycophenolic Acid 2 Busulfan 2 Biopsy 2 talimogene laherparepvec 1 pembrolizumab 1 fludarabine 1 duvelisib 1 Vincristine 1 Transplantation 1 Sirolimus 1 Radiotherapy 1 Prednisone 1 Methotrexate 1 Melphalan 1 Magnetic Resonance Spectroscopy 1 Gemcitabine 1 Etoposide 1 Cyclosporine 1 Brentuximab Vedotin 1 Blood Specimen Collection 1 Aclarubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Sezary Syndrome × Blood Specimen Collection × 90 days × Clear all

NCT07477769 2026-03-17

NIPALYMPHO

Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Sezary Syndrome, Ichthyosis, Lamellar

Data powered by HemOnc (CC BY 4.0) Colophon ⚡